2021 American Transplant Congress
The Gut Microbiome in Heart Transplantation: A Prospective Pilot Study
*Purpose: The contribution of the intestinal microbiome to alloimmunity in heart transplantation (HT) is unknown. We examined the fecal microbiota of HT recipients at the…2021 American Transplant Congress
Intravenous Immunoglobulin in Heart Transplant Recipients with Hypogammaglobulinemia and Infection
Houston Methodist Hospital, Houston, TX
*Purpose: Hypogammaglobulinemia (HGG) is a complication of solid organ transplantation which has been associated with increased risk of infections. HGG is commonly defined as a…2021 American Transplant Congress
Adult Combined Liver-Heart Transplantation: The United States Experience
*Purpose: Combined heart-liver transplantation (CHLT) is now being practiced with increasing regularity and improved outcomes in the United States. We performed the most comprehensive review…2021 American Transplant Congress
Impact of New Onset Diabetes After Transplantation on Heart Transplant Recipients
*Purpose: The purpose of this study is to investigate New Onset Diabetes After Transplantation (NODAT) incidence and its impact on post-transplant prognosis in adult heart…2021 American Transplant Congress
Allograft Discard Risk Index for Heart Transplantation
*Purpose: The number of patients awaiting heart transplantation (HTx) substantially exceeds the number of donor hearts transplanted each year, yet nearly 70% of consented donor…2021 American Transplant Congress
Outcomes of HLA Antibody Surveillance Protocol in Heart Transplant Patients – A Single-Center Retrospective Analysis
Baylor University Medical Center, Dallas, TX
*Purpose: Post-transplant care is multifaceted with protocols to provide oversight and maintain the standard of care. While institutional protocols for post-transplant HLA antibody surveillance after…2021 American Transplant Congress
Liver Biopsy as a Predictor in Risk Stratification for Heart Transplant Candidates
*Purpose: Patients undergoing workup for Orthotopic Heart Transplant (OHT) undergo multi-organ evaluation for risk stratification. While cirrhosis is a known predictor of poor outcomes in…2021 American Transplant Congress
Impact of a Pharmacist in an Outpatient Heart Transplant Clinic
1UNC Health Care, Chapel Hill, NC, 2Eshelman School of Pharmacy, Chapel Hill, NC
*Purpose: Data describing the impact of a pharmacist in ambulatory medication management of heart transplant recipients (HTRs) is lacking. Following the addition of an ambulatory…2021 American Transplant Congress
Significance of Repeated 1r Rejections in Heart Transplantation
1Yale New Haven Hospital, New Haven, CT, 2Yale University School of Medicine, New Haven, CT
*Purpose: 1R rejection is commonly seen in routine post-transplant biopsies. While presence of occasional 1R rejection is not considered to be detrimental, the significance of…2021 American Transplant Congress
Combined Heart-liver Transplantation in Patients with Familial Amyloidosis – Analysis of Optn/Unos Database
Virginia Commonwealth University, Richmond, VA
*Purpose: We compared the outcomes after combined heart-liver transplant (CHLT) for patients with Familial Amyloidosis (FA) versus other indications (primary cardiac:congenital heart disease and idiopathic…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 30
- Next Page »